Enterprise Value
-16.04M
Cash
118.6M
Avg Qtr Burn
-10.41M
Short % of Float
3.68%
Insider Ownership
0.21%
Institutional Own.
71.88%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Tildacerfont Details Congenital adrenal hyperplasia, Primary biliary cholangitis, Liver disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 2 Data readout | |
Phase 2 Data readout | ||
Tildacerfont Details Polycystic Ovary Syndrome | Phase 2 Update |